ADAR1 inhibitors therapy(BridGene Biosciences)

N/A

Report date: 2024/11/14 15:51:50
NME

Base Information

Drug NameADAR1 inhibitors therapy(BridGene Biosciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine Deaminase Acting On RNA 1-A inhibitors
TargetsAdenosine Deaminase Acting On RNA 1-A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBridGene Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesBridGene Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A